WHITE PAPER: HIV Update for Specialty Pharmacy
The Centers for Disease Control and Prevention (CDC) estimate that more than 1.2 million people are living with human immunodeficiency virus (HIV) in the United States, and nearly 13% of those afflicted are unaware of their condition. While progress has been made towards this disease state over the years, there is still more to be done. As providers of care for those infected with HIV, specialty pharmacies can play a vital role in the ongoing process.
This tactical guide will outline the latest research on HIV, new treatment options available, as well as analyzing spending data and what this means for the coming months.
This whitepaper will help you:
- Understand the progress that has been made so far for HIV
- Analyze vaccine research and successful findings
- Identify new and emerging drugs that keep the virus at bay
- Learn about high-tech innovations including gene sequencing and immunotherapy
Download the free whitepaper to learn more about this disease state so that prescribers, pharmacists, payers, and patients can work together to ensure positive outcomes.
The “HIV Update for Specialty Pharmacy” white paper is on its way for you to download. Check for an email from Mediware.